Paper41979751
Mean platelet volume-to-albumin ratio as a predictor of pathological complete response in HER2-positive breast cancer undergoing neoadjuvant chemotherapy.
Ayyıldız Sevim H and 5 others. Discov Oncol, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Mean platelet volume-to-albumin ratio as a predictor of pathological complete response in HER2-positive breast cancer undergoing neoadjuvant chemotherapy. Papers, record 41979751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41979751
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Mean platelet volume-to-albumin ratio as a predictor of pathological complete response in HER2-positive breast cancer undergoing neoadjuvant chemotherapy.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References30
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35127741 | Total Parenteral Nutrition Treatment Improves the Nutrition Status of Gynecological Cancer Patients by Improving Serum Albumin Level. | Front Med (Lausanne) | 2021 | https://conductscience.org/library/papers/35127741 | PubMed |
| 2 | 39450552 | Advances in predicting breast cancer driver mutations: Tools for precision oncology (Review). | Int J Mol Med | 2025 | https://conductscience.org/library/papers/39450552 | PubMed |
| 3 | 40282892 | Mean Platelet Volume-to-Albumin Ratio as a Predictor of Mortality in Patients with Febrile Neutropenia: An Observational Study. | Medicina (Kaunas) | 2025 | https://conductscience.org/library/papers/40282892 | PubMed |
| 4 | 23704196 | Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA). | Ann Oncol | 2013 | https://conductscience.org/library/papers/23704196 | PubMed |
| 5 | 17063500 | Low serum albumin levels and liver metastasis are powerful prognostic markers for survival in patients with carcinomas of unknown primary site. | Cancer | 2006 | https://conductscience.org/library/papers/17063500 | PubMed |
| 6 | 26418235 | Prognostic and predictive immune gene signatures in breast cancer. | Curr Opin Oncol | 2015 | https://conductscience.org/library/papers/26418235 | PubMed |
| 7 | 36869395 | Blood biomarkers as potential malnutrition screening alternatives among adult patients with cancer on treatment in oncology unit of jimma tertiary hospital: A cross-sectional analysis. | BMC Nutr | 2023 | https://conductscience.org/library/papers/36869395 | PubMed |
| 8 | 24529560 | Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis. | Lancet | 2014 | https://conductscience.org/library/papers/24529560 | PubMed |
| 9 | 28956830 | Platelet Integrins in Tumor Metastasis: Do They Represent a Therapeutic Target? | Cancers (Basel) | 2017 | https://conductscience.org/library/papers/28956830 | PubMed |
| 10 | 31695497 | Platelet Volume Is Reduced In Metastasing Breast Cancer: Blood Profiles Reveal Significant Shifts. | Cancer Manag Res | 2019 | https://conductscience.org/library/papers/31695497 | PubMed |
| 11 | 31159248 | Nutritional Laboratory Markers in Malnutrition. | J Clin Med | 2019 | https://conductscience.org/library/papers/31159248 | PubMed |
| 12 | 20690807 | Population-based estimate of the prevalence of HER-2 positive breast cancer tumors for early stage patients in the US. | Cancer Invest | 2010 | https://conductscience.org/library/papers/20690807 | PubMed |
| 13 | 39826475 | Tumor-infiltrating lymphocytes in HER2-positive breast cancer: potential impact and challenges. | ESMO Open | 2025 | https://conductscience.org/library/papers/39826475 | PubMed |
| 14 | 39036381 | The breast cancer tumor microenvironment and precision medicine: immunogenicity and conditions favoring response to immunotherapy. | J Natl Cancer Cent | 2024 | https://conductscience.org/library/papers/39036381 | PubMed |
| 15 | 29677116 | Human Cancer and Platelet Interaction, a Potential Therapeutic Target. | Int J Mol Sci | 2018 | https://conductscience.org/library/papers/29677116 | PubMed |
| 16 | 30288759 | Hypoalbuminemia: Pathogenesis and Clinical Significance. | JPEN J Parenter Enteral Nutr | 2019 | https://conductscience.org/library/papers/30288759 | PubMed |
| 17 | 32010567 | Prognostic biomarkers in stage IV non-small cell lung cancer (NSCLC): neutrophil to lymphocyte ratio (NLR), lymphocyte to monocyte ratio (LMR), platelet to lymphocyte ratio (PLR) and advanced lung cancer inflammation index (ALI). | Transl Lung Cancer Res | 2019 | https://conductscience.org/library/papers/32010567 | PubMed |
| 18 | 30305116 | Role of platelets and platelet receptors in cancer metastasis. | J Hematol Oncol | 2018 | https://conductscience.org/library/papers/30305116 | PubMed |
| 19 | 31148950 | Mean Platelet Volume (MPV): New Perspectives for an Old Marker in the Course and Prognosis of Inflammatory Conditions. | Mediators Inflamm | 2019 | https://conductscience.org/library/papers/31148950 | PubMed |
| 20 | 30912405 | Pretreatment Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte Ratio (PLR) as a Predictive Value of Hematological Markers in Cervical Cancer | Asian Pac J Cancer Prev | 2019 | https://conductscience.org/library/papers/30912405 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ALB | 213 | PubTator's text mining | https://conductscience.org/library/genes/213 | NCBI Gene |
| ERBB2 | 2064 | PubTator's text mining | https://conductscience.org/library/genes/2064 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41979751
GET https://conductscience.org/api/papers/v1/41979751/references?page=2